I have put together some revenue multiples used in some of the Amarin analyst reports, and these are as of Friday, December 7th closing, 20-Day Trading Average to smooth out any white noise movements in the stock. NFY indicates (2013 revenue) and NFY +1 indicates (2014 revenue).
As you can see from the indicate market pricing. Neptune is priced at a 4.79x revenue multiple, which Amarin SHOULD yield a significant premium to that due to efficacy, exclusivity, etc. (Right now only trading about 0.3x premium). Say 6.5x NFY+1 revenue would indicate $2.1 billion Enterprise Value, which shows that the current market pricing for Amarin is UNDERVALUED.
No comments:
Post a Comment